| UniProt ID | MTCH2_HUMAN | |
|---|---|---|
| UniProt AC | Q9Y6C9 | |
| Protein Name | Mitochondrial carrier homolog 2 | |
| Gene Name | MTCH2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 303 | |
| Subcellular Localization |
Mitochondrion inner membrane Multi-pass membrane protein . |
|
| Protein Description | The substrate transported is not yet known. Induces mitochondrial depolarization.. | |
| Protein Sequence | MADAASQVLLGSGLTILSQPLMYVKVLIQVGYEPLPPTIGRNIFGRQVCQLPGLFSYAQHIASIDGRRGLFTGLTPRLCSGVLGTVVHGKVLQHYQESDKGEELGPGNVQKEVSSSFDHVIKETTREMIARSAATLITHPFHVITLRSMVQFIGRESKYCGLCDSIITIYREEGILGFFAGLVPRLLGDILSLWLCNSLAYLVNTYALDSGVSTMNEMKSYSQAVTGFFASMLTYPFVLVSNLMAVNNCGLAGGCPPYSPIYTSWIDCWCMLQKEGNMSRGNSLFFRKVPFGKTYCCDLKMLI | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MADAASQVL ------CCHHHHHHH | 18.36 | 25944712 | |
| 6 | Phosphorylation | --MADAASQVLLGSG --CCHHHHHHHHCCC | 23.65 | 24043423 | |
| 12 | Phosphorylation | ASQVLLGSGLTILSQ HHHHHHCCCCCHHCC | 30.51 | 29116813 | |
| 15 | Phosphorylation | VLLGSGLTILSQPLM HHHCCCCCHHCCCCH | 24.33 | 29116813 | |
| 18 | Phosphorylation | GSGLTILSQPLMYVK CCCCCHHCCCCHHHE | 26.38 | 29116813 | |
| 22 | Sulfoxidation | TILSQPLMYVKVLIQ CHHCCCCHHHEHHHH | 4.62 | 28183972 | |
| 23 | Phosphorylation | ILSQPLMYVKVLIQV HHCCCCHHHEHHHHC | 12.56 | 29116813 | |
| 32 | Phosphorylation | KVLIQVGYEPLPPTI EHHHHCCCCCCCCCC | 18.60 | 24043423 | |
| 38 | Phosphorylation | GYEPLPPTIGRNIFG CCCCCCCCCCCCCCC | 33.84 | 24043423 | |
| 49 | S-palmitoylation | NIFGRQVCQLPGLFS CCCCCCHHCCCCHHH | 2.32 | 29575903 | |
| 56 | Phosphorylation | CQLPGLFSYAQHIAS HCCCCHHHHHHHHHH | 25.30 | - | |
| 57 | Phosphorylation | QLPGLFSYAQHIASI CCCCHHHHHHHHHHH | 11.71 | - | |
| 63 | Phosphorylation | SYAQHIASIDGRRGL HHHHHHHHHCCCCCC | 22.17 | - | |
| 72 | Phosphorylation | DGRRGLFTGLTPRLC CCCCCCCCCCCHHHC | 36.00 | 21406692 | |
| 75 | Phosphorylation | RGLFTGLTPRLCSGV CCCCCCCCHHHCCCH | 14.01 | 24719451 | |
| 79 | Glutathionylation | TGLTPRLCSGVLGTV CCCCHHHCCCHHCHH | 3.34 | 22555962 | |
| 79 | S-palmitoylation | TGLTPRLCSGVLGTV CCCCHHHCCCHHCHH | 3.34 | 29575903 | |
| 79 | S-nitrosylation | TGLTPRLCSGVLGTV CCCCHHHCCCHHCHH | 3.34 | 24105792 | |
| 80 | Phosphorylation | GLTPRLCSGVLGTVV CCCHHHCCCHHCHHH | 36.21 | 23312004 | |
| 90 | Ubiquitination | LGTVVHGKVLQHYQE HCHHHCHHHHHHHHH | 25.54 | - | |
| 95 | Phosphorylation | HGKVLQHYQESDKGE CHHHHHHHHHCCCCC | 10.87 | 20873877 | |
| 98 | Phosphorylation | VLQHYQESDKGEELG HHHHHHHCCCCCCCC | 29.15 | 20873877 | |
| 100 | Acetylation | QHYQESDKGEELGPG HHHHHCCCCCCCCCC | 76.99 | 26051181 | |
| 100 | Ubiquitination | QHYQESDKGEELGPG HHHHHCCCCCCCCCC | 76.99 | 21906983 | |
| 111 | Acetylation | LGPGNVQKEVSSSFD CCCCCHHHHHHHCHH | 56.66 | 26051181 | |
| 111 | Ubiquitination | LGPGNVQKEVSSSFD CCCCCHHHHHHHCHH | 56.66 | 21906983 | |
| 114 | Phosphorylation | GNVQKEVSSSFDHVI CCHHHHHHHCHHHHH | 22.74 | 30622161 | |
| 115 | Phosphorylation | NVQKEVSSSFDHVIK CHHHHHHHCHHHHHH | 39.95 | 30622161 | |
| 116 | Phosphorylation | VQKEVSSSFDHVIKE HHHHHHHCHHHHHHH | 27.47 | 30622161 | |
| 122 | Malonylation | SSFDHVIKETTREMI HCHHHHHHHHHHHHH | 48.17 | 32601280 | |
| 122 | Ubiquitination | SSFDHVIKETTREMI HCHHHHHHHHHHHHH | 48.17 | 21906983 | |
| 148 | Phosphorylation | FHVITLRSMVQFIGR CHHHHHHHHHHHHCC | 26.81 | - | |
| 149 | Sulfoxidation | HVITLRSMVQFIGRE HHHHHHHHHHHHCCC | 1.91 | 28183972 | |
| 157 | Phosphorylation | VQFIGRESKYCGLCD HHHHCCCCCCCCCCC | 27.80 | - | |
| 159 | Phosphorylation | FIGRESKYCGLCDSI HHCCCCCCCCCCCHH | 10.88 | 23403867 | |
| 165 | Phosphorylation | KYCGLCDSIITIYRE CCCCCCCHHEEEHHH | 18.20 | - | |
| 283 | Phosphorylation | GNMSRGNSLFFRKVP CCCCCCCEEEEEECC | 29.40 | 30266825 | |
| 293 | Acetylation | FRKVPFGKTYCCDLK EEECCCCCEEECCHH | 36.38 | 25825284 | |
| 293 | Ubiquitination | FRKVPFGKTYCCDLK EEECCCCCEEECCHH | 36.38 | - | |
| 300 | Ubiquitination | KTYCCDLKMLI---- CEEECCHHHCC---- | 20.57 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of MTCH2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MTCH2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MTCH2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| AL3A2_HUMAN | ALDH3A2 | physical | 26344197 | |
| AT1A1_HUMAN | ATP1A1 | physical | 26344197 | |
| AT2A2_HUMAN | ATP2A2 | physical | 26344197 | |
| ATPG_HUMAN | ATP5C1 | physical | 26344197 | |
| VA0D1_HUMAN | ATP6V0D1 | physical | 26344197 | |
| CLH1_HUMAN | CLTC | physical | 26344197 | |
| GNAI2_HUMAN | GNAI2 | physical | 26344197 | |
| RM37_HUMAN | MRPL37 | physical | 26344197 | |
| NDUAC_HUMAN | NDUFA12 | physical | 26344197 | |
| NDUA2_HUMAN | NDUFA2 | physical | 26344197 | |
| NDUA6_HUMAN | NDUFA6 | physical | 26344197 | |
| NDUB8_HUMAN | NDUFB8 | physical | 26344197 | |
| NDUB9_HUMAN | NDUFB9 | physical | 26344197 | |
| NDUS1_HUMAN | NDUFS1 | physical | 26344197 | |
| NDUS2_HUMAN | NDUFS2 | physical | 26344197 | |
| NDUS3_HUMAN | NDUFS3 | physical | 26344197 | |
| PHB_HUMAN | PHB | physical | 26344197 | |
| PHB2_HUMAN | PHB2 | physical | 26344197 | |
| RAB1A_HUMAN | RAB1A | physical | 26344197 | |
| RPN1_HUMAN | RPN1 | physical | 26344197 | |
| SDHB_HUMAN | SDHB | physical | 26344197 | |
| C560_HUMAN | SDHC | physical | 26344197 | |
| SGPL1_HUMAN | SGPL1 | physical | 26344197 | |
| TOM22_HUMAN | TOMM22 | physical | 26344197 | |
| QCR2_HUMAN | UQCRC2 | physical | 26344197 | |
| VDAC1_HUMAN | VDAC1 | physical | 26344197 | |
| VDAC2_HUMAN | VDAC2 | physical | 26344197 | |
| VDAC3_HUMAN | VDAC3 | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |